Which has grown faster, OCUL or PSNL?

Over the past five years, OCUL grew revenue faster — OCUL at a 10.03% CAGR versus PSNL at -3.33%.

How have OCUL and PSNL total returns compared?

Over the past 5 years, OCUL delivered -5.73% and PSNL delivered -1.75% annualized total return. Past performance doesn't predict future results.

Ocular Therapeutix, Inc. (OCUL) vs Personalis, Inc. (PSNL)

A side-by-side comparison of Ocular Therapeutix, Inc. and Personalis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

OCUL

Ocular Therapeutix, Inc.

$1.62B

$7.38HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT

PSNL

Personalis, Inc.

$1.70B

$15.96HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT

Total return — OCUL vs PSNL

growth of $100 · dividends reinvested · last 7y

OCUL +61.8% (+7.1%/yr)PSNL -42.4% (-7.6%/yr)OCUL compounded faster over this window

OCUL PSNL

OCUL vs PSNL: by the numbers

•PSNL is the larger company ($1.70B vs $1.62B market cap).
•Both run net losses; PSNL's is the smaller (-153.84% vs -579.10% net margin).
•OCUL grew revenue faster over the past five years (10.03% vs -3.33% CAGR).

Metrics side by side

Valuation

Metric	OCUL	PSNL
P/S ratio	31.04	24.45
P/B ratio	3.11	7.24

Profitability

Metric	OCUL	PSNL
Gross margin	87.11%	22.65%
Operating margin	-521.04%	-126.43%
Net margin	-579.10%	-153.84%
ROE	-57.97%	-45.58%
ROIC	-50.20%	-42.87%

Growth (annualized)

Metric	OCUL	PSNL
Revenue CAGR (5Y)	10.03%	-3.33%
Total return CAGR (5Y)	-5.73%	-1.75%

Frequently asked

Which has grown faster, OCUL or PSNL?: Over the past five years, OCUL grew revenue faster — OCUL at a 10.03% CAGR versus PSNL at -3.33%.
How have OCUL and PSNL total returns compared?: Over the past 5 years, OCUL delivered -5.73% and PSNL delivered -1.75% annualized total return. Past performance doesn't predict future results.

Go deeper

Full OCUL analysis Full PSNL analysis Interactive comparison tool

Dig into the metrics

Ocular Therapeutix ROE Personalis ROE Ocular Therapeutix operating margin Personalis operating margin Ocular Therapeutix revenue growth Personalis revenue growth Ocular Therapeutix free cash flow Personalis free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.